Literature DB >> 2052407

Inhibitory activity of IL-6 on malaria hepatic stages.

S Pied1, L Rénia, A Nüssler, F Miltgen, D Mazier.   

Abstract

Addition of recombinant interleukin-6 (IL-6) to Plasmodium yoelii hepatic cultures resulted in a specific dose-dependent inhibition of parasite development. Time course experiments showed that, without any direct effect on free sporozoites, IL-6 exerts its action during both the early phase of infection and during the subsequent maturation of the schizonts. Elicitation of the oxidative burst appears to be one mechanism by which IL-6 interferes with the development of hepatic phase. Catalase and superoxide dismutase, two scavengers of hydrogen peroxide and superoxide anions, reversed the IL-6 mediated parasiticidal activity.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2052407     DOI: 10.1111/j.1365-3024.1991.tb00276.x

Source DB:  PubMed          Journal:  Parasite Immunol        ISSN: 0141-9838            Impact factor:   2.280


  17 in total

Review 1.  Parasite heat-shock proteins and host responses: the balance between protection and immunopathology.

Authors:  D Mazier; D Mattei
Journal:  Springer Semin Immunopathol       Date:  1991

2.  In vitro activity of CD4+ and CD8+ T lymphocytes from mice immunized with a synthetic malaria peptide.

Authors:  L Rénia; M S Marussig; D Grillot; S Pied; G Corradin; F Miltgen; G Del Giudice; D Mazier
Journal:  Proc Natl Acad Sci U S A       Date:  1991-09-15       Impact factor: 11.205

3.  Plasmodium-host interactions directly influence the threshold of memory CD8 T cells required for protective immunity.

Authors:  Nathan W Schmidt; Noah S Butler; John T Harty
Journal:  J Immunol       Date:  2011-04-01       Impact factor: 5.422

4.  Vaccination with live Plasmodium yoelii blood stage parasites under chloroquine cover induces cross-stage immunity against malaria liver stage.

Authors:  Elodie Belnoue; Tatiana Voza; Fabio T M Costa; Anne Charlotte Grüner; Marjorie Mauduit; Daniela Santoro Rosa; Nadya Depinay; Michèle Kayibanda; Ana Margarida Vigário; Dominique Mazier; Georges Snounou; Photini Sinnis; Laurent Rénia
Journal:  J Immunol       Date:  2008-12-15       Impact factor: 5.422

5.  Differential effector pathways regulate memory CD8 T cell immunity against Plasmodium berghei versus P. yoelii sporozoites.

Authors:  Noah S Butler; Nathan W Schmidt; John T Harty
Journal:  J Immunol       Date:  2010-01-22       Impact factor: 5.422

6.  Kupffer cell elimination enhances development of liver schizonts of Plasmodium berghei in rats.

Authors:  S G Vreden; R W Sauerwein; J P Verhave; N Van Rooijen; J H Meuwissen; M F Van Den Broek
Journal:  Infect Immun       Date:  1993-05       Impact factor: 3.441

7.  Nitric oxide-mediated antiplasmodial activity in human and murine hepatocytes induced by gamma interferon and the parasite itself: enhancement by exogenous tetrahydrobiopterin.

Authors:  S Mellouk; S L Hoffman; Z Z Liu; P de la Vega; T R Billiar; A K Nussler
Journal:  Infect Immun       Date:  1994-09       Impact factor: 3.441

8.  Interferon-γ, a valuable surrogate marker of Plasmodium falciparum pre-erythrocytic stages protective immunity.

Authors:  Blanca-Liliana Perlaza; Jean-Pierre Sauzet; Karima Brahimi; Lbachir BenMohamed; Pierre Druilhe
Journal:  Malar J       Date:  2011-02-08       Impact factor: 2.979

9.  Inhibitory effect of TNF-α on malaria pre-erythrocytic stage development: influence of host hepatocyte/parasite combinations.

Authors:  Nadya Depinay; Jean Francois Franetich; Anne Charlotte Grüner; Marjorie Mauduit; Jean-Marc Chavatte; Adrian J F Luty; Geert-Jan van Gemert; Robert W Sauerwein; Jean-Michel Siksik; Laurent Hannoun; Dominique Mazier; Georges Snounou; Laurent Rénia
Journal:  PLoS One       Date:  2011-03-04       Impact factor: 3.240

10.  Immunization with a recombinant C-terminal fragment of Plasmodium yoelii merozoite surface protein 1 protects mice against homologous but not heterologous P. yoelii sporozoite challenge.

Authors:  L Rénia; I T Ling; M Marussig; F Miltgen; A A Holder; D Mazier
Journal:  Infect Immun       Date:  1997-11       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.